Novartis Oncology Enterprise Account Executive Salaries in Boulder
The average Novartis Oncology Enterprise Account Executive in Boulder earns an estimated $117,075 annually, which includes an estimated base salary of $90,033 with a $27,043 bonus. Novartis Oncology's Enterprise Account Executive compensation is $3,601 more than the US average for a Enterprise Account Executive. Enterprise Account Executive salaries at Novartis Oncology in Boulder can range from $52,000 - $205,000.
In Boulder, The Business Development Department at Novartis Oncology earns $1,459 more on average than the Product Department.
Last updated 3 years ago.
- $90,033
- avg. base
- $27,043
- avg. bonus
Enterprise Account Executive Salaries at Novartis Oncology
In Boulder, Enterprise Account Executives earn $6,549 more than Account Executives, and $65,129 less than Business Development Managers.
Compensation at Novartis Oncology by Department
In Boulder, The Business Development Department averages $1,459 more than the Product Department, and $35,060 less than the Communications Department
Enterprise Account Executive Compensation by Gender (All Companies)
The average female Enterprise Account Executive at companies similar size to Novartis Oncology reported making $115,417, while the average male Enterprise Account Executive at similar sized companies reported making $130,365.
Enterprise Account Executive Compensation by Ethnicity (All Companies)
The average African American/Black Enterprise Account Executive at companies similar size to Novartis Oncology reported making $130,663, while the average Hispanic or Latino Enterprise Account Executive at similar sized companies reported making $107,000.
How Enterprise Account Executives at Novartis Oncology Rate Their Compensation
The majority of Enterprise Account Executives at Novartis Oncology believe they're not compensated fairly. 100% of Enterprise Account Executives at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology
